MarketStudyReport.com adds “Global Imipenem (CAS 64221-86-9) Market Outlook 2016-2021” new report to its research database. The report spread across 100 pages with table and figures in it.
Imipenem (Primaxin) is an intravenous -lactam antibiotic discovered by Merck scientists Burton Christensen, William Leanza, and Kenneth Wildonger in 1980. It was the first member of the carbapenem class of antibiotics. Carbapenems are highly resistant to the -lactamase enzymes produced by many multiple drug-resistant Gram-negative bacteria, thus play a key role in the treatment of infections not readily treated with other antibiotics.
Browse full table of contents and data tables at https://www.marketstudyreport.com/reports/global-imipenem-cas-64221-86-9-market-outlook-2016-2021/
This report provides detailed analysis of worldwide markets for Imipenem (CAS 64221-86-9) from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Imipenem (CAS 64221-86-9) market and further lays out an analysis of the factors influencing the supply/demand for Imipenem (CAS 64221-86-9), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.
The report, Global Imipenem (CAS 64221-86-9) Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Imipenem (CAS 64221-86-9) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Imipenem (CAS 64221-86-9) market are Hospira (USA), Unimark Remedies (India), ACS Dobfar (Italy), High Tech Pharm (Korea), Zhejiang Hisun (China), TUL (China), Shenzhen Haibin (China), Zhejiang Jiuzhou (China), among others.
The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Imipenem (CAS 64221-86-9) industry has been provided.
To receive personalized assistance, write to us @ email@example.com with the report title in the subject line along with your questions or call us at +1 866-764-2150